POLITECNICO DI BARI - Catalogo dei prodotti della Ricerca

Zaccaria, Gian Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.385
EU - Europa 2.158
AS - Asia 1.461
SA - Sud America 454
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 6.498
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.318
RU - Federazione Russa 1.403
SG - Singapore 481
BR - Brasile 378
IT - Italia 340
CN - Cina 307
VN - Vietnam 200
HK - Hong Kong 127
KR - Corea 82
FR - Francia 71
BD - Bangladesh 69
JP - Giappone 61
DE - Germania 57
FI - Finlandia 46
GB - Regno Unito 42
SE - Svezia 42
NL - Olanda 38
CA - Canada 32
IE - Irlanda 30
AR - Argentina 26
IN - India 23
AT - Austria 22
MX - Messico 19
PL - Polonia 19
ES - Italia 17
TR - Turchia 17
EC - Ecuador 15
IQ - Iraq 15
ZA - Sudafrica 13
ID - Indonesia 12
CO - Colombia 9
UZ - Uzbekistan 8
CL - Cile 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
JO - Giordania 6
PE - Perù 6
PK - Pakistan 6
AZ - Azerbaigian 5
LT - Lituania 5
MA - Marocco 5
UA - Ucraina 5
VE - Venezuela 5
AM - Armenia 4
GE - Georgia 4
GR - Grecia 4
IL - Israele 4
KE - Kenya 4
MY - Malesia 4
NP - Nepal 4
DZ - Algeria 3
LB - Libano 3
PY - Paraguay 3
SA - Arabia Saudita 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
BZ - Belize 2
CH - Svizzera 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HN - Honduras 2
PA - Panama 2
RS - Serbia 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
DK - Danimarca 1
EE - Estonia 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LV - Lettonia 1
PR - Porto Rico 1
PT - Portogallo 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
TG - Togo 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.498
Salva come PNG Salva come JPEG
Città #
Dallas 1.110
Moscow 315
Singapore 281
Ashburn 128
Hong Kong 122
San Jose 119
The Dalles 99
Rome 95
New York 92
Hefei 83
Seoul 82
Council Bluffs 78
Ho Chi Minh City 66
Santa Clara 58
Tokyo 58
Lauterbourg 52
Boardman 50
Hanoi 50
Los Angeles 43
Bari 40
Kent 38
Helsinki 35
São Paulo 33
Conversano 32
Dublin 30
Amsterdam 29
Beijing 23
West Jordan 20
Frankfurt am Main 17
Ogden 17
Warsaw 17
Denver 15
Orem 15
Poplar 15
Rio de Janeiro 15
Washington 15
Vienna 13
Düsseldorf 12
Milan 12
Montreal 12
Johannesburg 11
Brooklyn 10
Chicago 10
Munich 10
Chennai 9
Da Nang 9
Houston 9
Porto Alegre 9
Atlanta 8
Boston 8
Nuremberg 8
Zola Predosa 8
Campinas 7
Fasano 7
Lappeenranta 7
Mexico City 7
Phoenix 7
Tashkent 7
Toronto 7
Amman 6
Assago 6
Belo Horizonte 6
Brasília 6
Chandler 6
Hillsboro 6
London 6
Molfetta 6
Quito 6
San Francisco 6
Turin 6
Ankara 5
Baku 5
Biên Hòa 5
Catania 5
Caxias do Sul 5
Haiphong 5
Ninh Bình 5
Osasco 5
Philadelphia 5
Athens 4
Baghdad 4
Can Tho 4
Curitiba 4
Dubai 4
Guangzhou 4
Hải Dương 4
Lima 4
Manchester 4
Nairobi 4
Naples 4
Portsmouth 4
Ribeirão Preto 4
Santo André 4
Stockholm 4
Tbilisi 4
Thái Bình 4
Turku 4
Buenos Aires 3
Bắc Ninh 3
Cairo 3
Totale 3.786
Salva come PNG Salva come JPEG
Nome #
Highly reliable personalized noninvasive hemoglobin estimation by using Vision Transformers and dual fine-tuning 833
A multimodal framework for assessing the link between pathomics, transcriptomics, and pancreatic cancer mutations 204
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial 180
A COMPLETELY GENETIC PROGNOSTIC MODEL OVERCOMES CLINICAL PROGNOSTICATORS IN MANTLE CELL LYMPHOMA: RESULTS FROM THE MCL0208 TRIAL FROM THE FONDAZIONE ITALIANA LINFOMI (FIL) 173
Validation of Argo (Automatic record generator for Onco-Hematology), a New App Supporting the Automatic Conversion of Paper-Based Pathology Reports in Standardized Ecrfs 170
Development and validation of a machine learning prognostic model based on an epigenomic signature in patients with pancreatic ductal adenocarcinoma 167
A Decision-tree Approach to Stratify DLBCL Risk Based on Stromal and Immune Microenvironment Determinants 166
Comprehensive Minimal Residual Disease (MRD) Analysis of the Fondazione Italiana Linfomi (FIL) MCL0208 Clinical Trial for Younger Patients with Mantle Cell Lymphoma: A Kinetic Model Ensures a More Refined Risk Stratification 163
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the FIL MCL0208 trial 162
Primary, bilateral and diffuse renal non‐hodgkin’s lymphoma in a young woman suffering from turner syndrome 161
Integrative Analysis of Baseline Prognostic Features and Achievement of Minimal Residual Disease Negativity As Predictors of Early Relapse in Transplant-Eligible Multiple Myeloma Patients 161
A Digital Gene-Expression Signature Supports Mediastinal Gray Zone Lymphoma Stratification within Classical Hodgkin or Primary Mediastinal B-Cell Lymphoma 158
The Engineered MIPI (e-MIPI), a Candidate Data-Mining Based Mantle Cell Lymphoma Prognostic Index Developed from the Dataset of the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial 155
A time-dependent explainable radiomic analysis from the multi-omic cohort of CPTAC-Pancreatic Ductal Adenocarcinoma 151
ARGO 2.0: a Hybrid NLP/ML Framework for Diagnosis Standardization 148
Predictive Model of Early Relapse in Newly Diagnosed Multiple Myeloma: Analysis from a Pooled Dataset 145
IgM-Gammopathies Transformed into Aggressive Lymphoma: Incidence, Basal Clinical Features and Outcome of a Registry Based, Spanish Retrospective Series 142
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma 141
Dissecting MRD Kinetics By Automated Computational Analysis to Improve Outcome Prediction in Mantle Cell Lymphoma: A Bioinformatic Substudy from the Fondazione Italiana Linfomi (FIL) MCL0208 Clinical Trial 141
P1245: CLINICAL IMPACT OF IMMUNOGLOBULIN HEAVY CHAIN REPERTOIRE IN MANTLE CELL LYMPHOMA: A STUDY FROM THE FONDAZIONE ITALIANA LINFOMI (FIL) PHASE III MCL0208 TRIAL 139
6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival 129
A new ensemble method for detecting anomalies in gene expression matrices 129
Electronic case report forms generation from pathology reports by ARGO, automatic record generator for onco-hematology 126
Adenosine pathway inhibitors: novel investigational agents for the treatment of metastatic breast cancer 121
NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma 121
An Approach Based on Process Modeling for Implementing a Health Information Technology in Clinical Practice 116
SurvIAE: Survival prediction with Interpretable Autoencoders from Diffuse Large B-Cells Lymphoma gene expression data 116
A targeted gene signature stratifying mediastinal gray zone lymphoma into classical HL-like or PMBL-like subtypes 112
Data quality improvement of a multicenter clinical trial dataset 109
Determining Outcome in IgM Gammopathies: Integration of Molecular, Flow Cytometry and Clinical Factors in an International, Multicenter Series (the SAL-TO Study) 108
Unraveling MRD Dynamics to Enhance Outcome Prediction in Mantle Cell Lymphoma—Insights from the Fondazione Italiana Linfomi MCL0208 Clinical Trial 107
Development and validation of a simplified score to predict early relapse in newly diagnosed multiple myeloma in a pooled dataset of 2,190 patients 106
Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes 99
Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial 93
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing 92
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network 88
Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia 86
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma 85
Multimodal framework for TACE treatment response prediction in patients with hepatocellular carcinoma 83
ZebraBeat : A flexible platform for the analysis of the cardiac rate in zebrafish embryos 82
Delphi, a Data Warehouse to Discover Associations between Variables in Clinical Trials: Application to the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial 81
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 79
Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML 78
Lean Perspectives in an Organizational Change in a Scientific Direction of an Italian Research Institute: Experience of the Cancer Institute of Bari 77
Pharmacogenomics Drives Lenalidomide Efficacy and MRD Kinetics in Mantle Cell Lymphoma after Autologous Transplantation: Results from the MCL0208 Multicenter, Phase III, Randomized Clinical Trial from the Fondazione Italiana Linfomi (FIL) 74
Targeted Locus Amplification (TLA): A Novel Next Generation Sequencing (NGS) Technology to Detect New Molecular Markers and Monitoring Minimal Residual Disease (MRD) in Mantle Cell and Follicular Lymphoma 69
AI-derived five-gene signature predicts risk in multiple myeloma under bortezomib-based therapy 49
The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial 37
Pharmacokinetic-pharmacodynamic modeling of tumor angiogenesis unveils the need for time-adjustable drug regimens 33
Development and independent validation of explainable radiomics-based machine learning models for prognosis in colorectal liver metastases 23
Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)‐MCL0208 clinical trial 7
Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study 6
Totale 6.581
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.563
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 0 0 0 0 0 1 3
2022/2023145 1 0 0 2 1 3 0 2 11 107 15 3
2023/2024406 32 17 18 10 104 98 5 0 29 34 1 58
2024/20251.021 19 6 91 8 52 27 58 66 192 160 240 102
2025/20265.005 115 503 1.047 569 255 448 918 563 126 170 181 110
Totale 6.581